A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Trial Summary
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or non-prescription drugs, including vitamins and herbal supplements, at least 7 days before the study and throughout its duration, except for acetaminophen, which is allowed in limited amounts.
What is the purpose of this trial?
This trial is testing a new drug called CB03-154 to help people with epilepsy. The study aims to see if the drug is safe, how well patients can handle it, and how the body processes it. Researchers are also looking at whether taking the drug with food changes its effects.
Research Team
Frank Lee, M.D
Principal Investigator
Frontage Clinical Services, Inc.
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive single and multiple ascending oral doses of CB03-154 or placebo in a fasted state for 14 consecutive days
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CB03-154
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shanghai Zhimeng Biopharma, Inc.
Lead Sponsor